MONROVIA, Calif. (AP) _ Xencor Inc. (XNCR) on Monday reported third-quarter net income of $3.2 million, after reporting a loss in the same period a year earlier.
The Monrovia, California-based company said it had net income of 5 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $29 million in the period.
Xencor shares have increased 72 percent since the beginning of the year. The stock has climbed 87 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR